Capability-Based Routes for Autonomous Vehicles

The pursuit of vehicle automation is an ongoing trend in the automotive industry. Particularly challenging is the goal of introducing driverless autonomous vehicles (AVs) into road traffic. To realize this vision, a targeted development of autonomous driving functions is essential. However, a targeted development process is only possible if the driving functions are tailored as appropriately and completely as possible to the operational design domain (ODD). Regardless of use case, all AVs have one thing in common: driving at least one route from A to B - whether simple or complex. For operational purposes, it is therefore necessary to ensure that the driving requirements (DRs) of the potential routes within the ODD do not exceed the driving capabilities (DCs) of the AVs. Currently, there is no approach that accomplishes the identification of exceeded capabilities. This work presents a method for route-based specification of DRs and DCs for AVs. It addresses the core research question of how to identify routes with DRs that do not exceed the DCs of AVs. An initial analysis reveals the dependencies between route and DRs. Thereby, the scenery defined in the ODD is found to be a fundamental basis for the specification of behavioral requirements as part of the DRs. In combination with the applicable traffic rules, the scenery elements define the behavioral limits for AVs. These limits are specifically extracted and classified as behavioral demands from the scenery using an analysis of these combinations. To enable a route-based specification of DRs, the behavioral demands are modeled as behavior spaces and transformed into a generic map representation - the Behavior-Semantic Scenery Description (BSSD). Based on the BSSD, a method is developed that generates behavioral requirements based on the route-constrained concatenation of behavior spaces. As a result, in addition to the method itself, the associated behavioral requirements are available as a basis for the route-based specification of DRs and DCs. Constraints for the specification are defined by the developed concept for the matching of DRs and DCs. It is shown that the DRs are strongly dependent on the geometry and property of the scenery elements, so that equal behavioral requirements do not necessarily imply equal DRs. These dependencies are used for the specification enabling the definition of matching criteria for a selection of DRs and corresponding DCs. To realize the matching, a capability-based route search is developed and implemented. The route search incorporates all elaborated results of the work enabling the whole approach to be evaluated by applying it to a real road network. The evaluation shows that the identification of feasible routes for AVs based on the scenery is possible and which hurdles based on identified deficits still have to be overcome

Towards Safety Concepts for Automated Vehicles by the Example of the Project UNICARagil

Striving towards deployment of SAE level 4+ vehicles in public traffic, researchers and developers face several challenges due to the targeted operation in an open environment. Due to the absence of a human supervisor, ensuring and validating safety while driving automatically is one of the key challenges. The arising complexity of the technical system must be handled during the entire research and development process. In this contribution, we outline the coherence of different safety-activities in the research project UNICARagi/. We derive high-level safety requirements and present the central safety mechanisms applied to automated diriving. Moreover, we outline the approaches of the project UNICARagi/ to address the validation challenge for automated vehicles. In order to demonstrate the overall approach towards a coherent safety argumentation, the connection of high-level safety requirements, safety mechanisms, as weil as validation approaches is illustrated by means of a selected example scenario

Separation of atomic and molecular ions by ion mobility with an RF carpet

Gas-filled stopping cells are used at accelerator laboratories for the thermalization of high-energy radioactive ion beams. Common challenges of many stopping cells are a high molecular background of extracted ions and limitations of extraction efficiency due to space-charge effects. At the FRS Ion Catcher at GSI, a new technique for removal of ionized molecules prior to their extraction out of the stopping cell has been developed. This technique utilizes the RF carpet for the separation of atomic ions from molecular contaminant ions through their difference in ion mobility. Results from the successful implementation and test during an experiment with a 600~MeV/u $^{124}$Xe primary beam are presented. Suppression of molecular contaminants by three orders of magnitude has been demonstrated. Essentially background-free measurement conditions with less than $1~\%$ of background events within a mass-to-charge range of 25 u/e have been achieved. The technique can also be used to reduce the space-charge effects at the extraction nozzle and in the downstream beamline, thus ensuring high efficiency of ion transport and highly-accurate measurements under space-charge-free conditions.Comment: 8 pages, 4 figure

A time-resolved proteomic and prognostic map of COVID-19.

COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection to severe organ damage and death. We characterized the time-dependent progression of the disease in 139 COVID-19 inpatients by measuring 86 accredited diagnostic parameters, such as blood cell counts and enzyme activities, as well as untargeted plasma proteomes at 687 sampling points. We report an initial spike in a systemic inflammatory response, which is gradually alleviated and followed by a protein signature indicative of tissue repair, metabolic reconstitution, and immunomodulation. We identify prognostic marker signatures for devising risk-adapted treatment strategies and use machine learning to classify therapeutic needs. We show that the machine learning models based on the proteome are transferable to an independent cohort. Our study presents a map linking routinely used clinical diagnostic parameters to plasma proteomes and their dynamics in an infectious disease

Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01

Background: Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there has been increasing urgency to identify pathophysiological characteristics leading to severe clinical course in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Human leukocyte antigen alleles (HLA) have been suggested as potential genetic host factors that affect individual immune response to SARS-CoV-2. We sought to evaluate this hypothesis by conducting a multicenter study using HLA sequencing. Methods: We analyzed the association between COVID-19 severity and HLAs in 435 individuals from Germany (n = 135), Spain (n = 133), Switzerland (n = 20) and the United States (n = 147), who had been enrolled from March 2020 to August 2020. This study included patients older than 18 years, diagnosed with COVID19 and representing the full spectrum of the disease. Finally, we tested our results by meta-analysing data from prior genome-wide association studies (GWAS). Findings: We describe a potential association of HLA-C*04:01 with severe clinical course of COVID-19. Carriers of HLA-C*04:01 had twice the risk of intubation when infected with SARS-CoV-2 (risk ratio 1.5 [95% CI 1.1-2.1], odds ratio 3.5 [95% CI 1.9-6.6], adjusted p-value = 0.0074). These findings are based on data from four countries and corroborated by independent results from GWAS. Our findings are biologically plausible, as HLA-C*04:01 has fewer predicted bindings sites for relevant SARS-CoV-2 peptides compared to other HLA alleles. Interpretation: HLA-C*04:01 carrier state is associated with severe clinical course in SARS-CoV-2. Our findings suggest that HLA class I alleles have a relevant role in immune defense against SARS-CoV-2. Funding: Funded by Roche Sequencing Solutions, Inc

Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study

Purpose: Adequate patient allocation is pivotal for optimal resource management in strained healthcare systems, and requires detailed knowledge of clinical and virological disease trajectories. The purpose of this work was to identify risk factors associated with need for invasive mechanical ventilation (IMV), to analyse viral kinetics in patients with and without IMV and to provide a comprehensive description of clinical course. Methods: A cohort of 168 hospitalised adult COVID-19 patients enrolled in a prospective observational study at a large European tertiary care centre was analysed. Results: Forty-four per cent (71/161) of patients required invasive mechanical ventilation (IMV). Shorter duration of symptoms before admission (aOR 1.22 per day less, 95% CI 1.10-1.37, p < 0.01) and history of hypertension (aOR 5.55, 95% CI 2.00-16.82, p < 0.01) were associated with need for IMV. Patients on IMV had higher maximal concentrations, slower decline rates, and longer shedding of SARS-CoV-2 than non-IMV patients (33 days, IQR 26-46.75, vs 18 days, IQR 16-46.75, respectively, p < 0.01). Median duration of hospitalisation was 9 days (IQR 6-15.5) for non-IMV and 49.5 days (IQR 36.8-82.5) for IMV patients. Conclusions: Our results indicate a short duration of symptoms before admission as a risk factor for severe disease that merits further investigation and different viral load kinetics in severely affected patients. Median duration of hospitalisation of IMV patients was longer than described for acute respiratory distress syndrome unrelated to COVID-19

Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study.

Funder: Humboldt-Universität zu Berlin (1034)PURPOSE: Adequate patient allocation is pivotal for optimal resource management in strained healthcare systems, and requires detailed knowledge of clinical and virological disease trajectories. The purpose of this work was to identify risk factors associated with need for invasive mechanical ventilation (IMV), to analyse viral kinetics in patients with and without IMV and to provide a comprehensive description of clinical course. METHODS: A cohort of 168 hospitalised adult COVID-19 patients enrolled in a prospective observational study at a large European tertiary care centre was analysed. RESULTS: Forty-four per cent (71/161) of patients required invasive mechanical ventilation (IMV). Shorter duration of symptoms before admission (aOR 1.22 per day less, 95% CI 1.10-1.37, p < 0.01) and history of hypertension (aOR 5.55, 95% CI 2.00-16.82, p < 0.01) were associated with need for IMV. Patients on IMV had higher maximal concentrations, slower decline rates, and longer shedding of SARS-CoV-2 than non-IMV patients (33 days, IQR 26-46.75, vs 18 days, IQR 16-46.75, respectively, p < 0.01). Median duration of hospitalisation was 9 days (IQR 6-15.5) for non-IMV and 49.5 days (IQR 36.8-82.5) for IMV patients. CONCLUSIONS: Our results indicate a short duration of symptoms before admission as a risk factor for severe disease that merits further investigation and different viral load kinetics in severely affected patients. Median duration of hospitalisation of IMV patients was longer than described for acute respiratory distress syndrome unrelated to COVID-19

A time-resolved proteomic and prognostic map of COVID-19

COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection to severe organ damage and death. We characterized the time-dependent progression of the disease in 139 COVID-19 inpatients by measuring 86 accredited diagnostic parameters, such as blood cell counts and enzyme activities, as well as untargeted plasma proteomes at 687 sampling points. We report an initial spike in a systemic inflammatory response, which is gradually alleviated and followed by a protein signature indicative of tissue repair, metabolic reconstitution, and immunomodulation. We identify prognostic marker signatures for devising risk-adapted treatment strategies and use machine learning to classify therapeutic needs. We show that the machine learning models based on the proteome are transferable to an independent cohort. Our study presents a map linking routinely used clinical diagnostic parameters to plasma proteomes and their dynamics in an infectious disease